Antibiotics Safe with Leflunomide
Most antibiotics can be safely given with leflunomide, but rifampin should be avoided as it significantly increases leflunomide levels, and careful monitoring is required when combining leflunomide with hepatotoxic antibiotics like isoniazid.
Key Drug Interactions
Rifampin - AVOID
- Rifampin increases leflunomide levels and should not be used concurrently 1, 2, 1
- This interaction is specifically highlighted in FDA labeling and multiple guidelines
- If tuberculosis treatment is necessary, alternative regimens should be considered
Isoniazid - Use with Caution
- When treating latent tuberculosis with isoniazid in patients on leflunomide, intensive liver function monitoring is mandatory 3
- Both drugs are hepatotoxic, creating additive risk
- Monitor LFTs monthly during co-administration rather than the standard every 6-8 weeks 3
Methotrexate Considerations
- While methotrexate is not an antibiotic, the FDA label notes that leflunomide plus methotrexate shows no pharmacokinetic interaction but increases hepatotoxicity risk 1, 4
- This principle applies to any hepatotoxic antimicrobial agent
Safe Antibiotic Options
The following antibiotics have no documented problematic interactions with leflunomide:
- Beta-lactams (penicillins, cephalosporins, carbapenems) - no interactions documented 5, 6, 7
- Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) - safe to use 5, 7
- Macrolides (azithromycin, clarithromycin) - no documented interactions 5
- Tetracyclines (doxycycline, minocycline) - safe 5
- Aminoglycosides (gentamicin, tobramycin) - no interactions 6
- Metronidazole - safe for anaerobic coverage 6
- Vancomycin and linezolid - no documented interactions 5
Monitoring Requirements
Standard monitoring for leflunomide continues during antibiotic therapy:
- CBC with differential and LFTs monthly for first 6 months, then every 6-8 weeks 8, 2, 1
- Increase monitoring frequency to monthly if using hepatotoxic antibiotics like isoniazid 3
Special Considerations
Acyclovir Interaction
- Research shows leflunomide increases kidney accumulation of acyclovir by inhibiting renal transporters (OAT1/3 and MRP2) 9
- This increases acyclovir's plasma concentration and kidney/plasma ratio
- While not contraindicated, monitor renal function more closely when combining these agents
- Consider dose adjustment of acyclovir if renal function changes
Immunosuppression Context
- Leflunomide increases infection risk through immunosuppression 8, 1
- The need for antibiotics may be more frequent in leflunomide-treated patients
- Leflunomide has some intrinsic antiviral properties, which may be beneficial 10
Clinical Algorithm
When prescribing antibiotics to a patient on leflunomide:
- Avoid rifampin - choose alternative TB regimen if needed
- For common infections - use standard antibiotics (beta-lactams, fluoroquinolones, macrolides) without dose adjustment
- For TB treatment with isoniazid - increase LFT monitoring to monthly
- For acyclovir - monitor renal function closely
- Continue baseline leflunomide monitoring throughout antibiotic course